Statement by Julian Lob-Levyt, GAVI Alliance Executive Secretary at the conference on Innovative Financing for Development
Statement by Julian Lob-Levyt, GAVI Alliance Executive Secretary at the conference on Innovative Financing for Development
2 March 2006
GAVI commends France and the UK for their work in developing innovative ways to finance achieving the Millennium Development Goals. In particular, GAVI welcomes their decision to support the International Financing Facility for Immunization, which will save millions of children by giving them access to vaccines and improving health systems in developing countries.
Conference on Innovative Financing for Development
Geneva, 2 March 2006 - GAVI congratulates France and the UK for their years of work invested in the search for creative new ways to pay for the measures that will be needed to meet the Millennium Development Goals. GAVI takes particular note of their decision to support an initiative that will save the lives of millions of the world's poorest children through the use of vaccines and the development of health systems.
The Paris Conference on Innovative Development Financing Mechanisms, which took place from February 28 to March 1 under the direction of President Chirac, demonstrates clearly that some governments have now made significant advances in fulfilling their pledge to meet the Millennium Development Goals.
GAVI reminds all concerned that, if 2005 was the year for making commitments, 2006 has to be the year during which the promises are fulfilled.
With the support of France, announced in detail on February 28th, and Great Britain, Norway, Sweden, Italy and Spain, we are preparing to launch the International Finance Facility for Immunization (IFFIm). This first-ever mechanism for using capital markets to obtain development funds is expected to raise US$4 billion and to prevent 5 million child deaths between 2005-2015, and more than 5 million future deaths among adults.
During the conference in Paris, the governments of France and the UK also announced the terms of an agreement that will move forward the development of the International Finance Facility for Immunization.
They will participate as well in a new French initiative that will use taxes on airline ticket sales to provide universal access to drugs against AIDS through 2010. France's launch of the Air Solidarity Contribution initiative in July will in the future raise funds to purchase drugs needed to fight pandemics, such as AIDS, tuberculosis and malaria, which are crippling poor countries.
This sense that complex problems require creative solutions is also behind a second initiative that holds great promise. Under an AMC (Advanced Market Commitment), donors promise to help finance the purchase of vaccines if and when they are developed and if countries ask for them. AMCs will generate the necessary funds to accelerate the research and production of urgently needed vaccines. GAVI and the World Bank will give their recommendations on the implementation of such a mechanism at the next G7 Meeting in April.
France is now demonstrating, through both word and deed, that it is ready to act to move beyond traditional forms of development assistance to fight global poverty.
The commitments made by the governments of France, Brazil and the United Kingdom and the other countries that have decided to support innovative financing mechanisms are an embodiment of this new spirit. They demonstrate that governments, having pledged through the Millennium Development Goals to dramatically reduce poverty in poor countries by 2015, are now concentrating on the practical steps required to fulfill this promise.
[Français]
Share this article
Restricted Access Library
The material in this Restricted Access Library is intended to be accessed only by persons with residence within the territory of a Member State of the European Union and is not intended to be viewed by any other persons. The material in this Restricted Access Library is provided by IFFIm for information purposes only and the materials contained herein were accurate only as of their respective dates. Certain information in the materials contained herein is not intended to be, and is not, current. IFFIm accepts no obligation to update any material contained herein.
Persons with residence outside the territory of a Member State of the European Union who have access to or consult any materials posted in this Restricted Access Library should refrain from any action in respect of the securities referred to in such materials and are otherwise required to comply with all applicable laws and regulations in their country of residence.
By clicking Access restricted content: DYNAMIC-LINK-TEXT I confirm that I have read and understood the foregoing and agree that I will be bound by the restrictions and conditions set forth on this page.
The materials in this Restricted Access Library are for distribution only to persons who are not a "retail client" within the meaning of section 761G of the Corporations Act 2001 of Australia and are also sophisticated investors, professional investors or other investors in respect of whom disclosure is not required under Part 6D.2 of the Corporations Act 2001 of Australia and, in all cases, in such circumstances as may be permitted by applicable law in any jurisdiction in which an investor may be located.
The materials in this Restricted Access Library and any documents linked from it are not for access or distribution in any jurisdiction where such access or distribution would be illegal. All of the securities referred to in this Restricted Access Library and in the linked documents have been sold and delivered. The information contained herein and therein does not constitute an offer for sale in the United States or in any other country. The securities described herein and therein have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), and may not be offered or sold in the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with any applicable state securities laws.
Each person accessing the Restricted Access Library confirms that they are a person who is entitled to do so under all applicable laws, regulations and directives in all applicable jurisdictions. Neither IFFIm nor any of their directors, employees, agents or advisers accepts any liability whatsoever for any loss (including, without limitation, any liability arising from any fault or negligence on the part of IFFIm or its respective directors, employees, agents or advisers) arising from access to Restricted Access Library by any person not entitled to do so.
Reflections on IFFIm: an interview with Rachel Turner
14 November 2024